Vascular Access Device Market Overview
The global vascular access device (VAD) market is entering a period of steady expansion as healthcare systems face a growing burden of chronic diseases, rising hospitalization rates, increasing chemotherapy and dialysis procedures, and greater demand for reliable intravenous and infusion therapy. Vascular access devices play a critical role in the delivery of medications, fluids, blood products, nutrition, and other therapies across hospitals, outpatient facilities, and home-care environments.
According to MarketsandMarkets, the global vascular access device market is projected to grow from USD 6.29 billion in 2026 to USD 8.70 billion by 2031, registering a CAGR of 6.7% during 2026–2031. The market was valued at USD 5.94 billion in 2025.
The market is also evolving technologically. Manufacturers are increasingly developing safety-engineered catheters, antimicrobial and antithrombogenic coatings, ultrasound-guided access systems, longer-dwell peripheral devices, and integrated insertion platforms designed to improve clinical outcomes and reduce complications.
Key Market Growth Drivers
Rising Prevalence of Chronic Diseases
The growing global incidence of cancer, diabetes, cardiovascular disorders, kidney disease, and other chronic conditions is one of the strongest drivers of vascular access device demand. Patients with these conditions frequently require repeated or long-term drug administration, chemotherapy, dialysis, blood transfusions, and fluid therapy.
An aging global population is further increasing the number of patients requiring vascular access, particularly those receiving complex and prolonged treatments.
Increasing Chemotherapy and Dialysis Procedures
The expansion of oncology and renal-care services is creating sustained demand for central venous catheters, peripheral access devices, and other specialized vascular access technologies. Long-term treatment programs require dependable access that can remain functional while minimizing infection, thrombosis, and catheter-related complications.
Growing Emphasis on Infection Prevention
Healthcare providers are placing greater emphasis on preventing catheter-related bloodstream infections (CRBSIs) and other vascular access complications. This is encouraging adoption of antimicrobial-coated and antithrombogenic devices, closed systems, safety-engineered catheters, and improved securement technologies.
Expansion of Outpatient and Home-Based Care
Infusion therapy is increasingly moving beyond traditional hospital environments into ambulatory clinics and home healthcare. This shift is creating demand for vascular access products that are easier to place, comfortable for patients, reliable for extended use, and suitable for decentralized care.
Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122149686
Technology Trends Transforming the Market
The vascular access device industry is moving from conventional catheterization techniques toward more advanced and patient-focused solutions.
Ultrasound-guided vascular access is becoming increasingly important because it can improve visualization of veins, support accurate placement, and help clinicians manage patients with difficult vascular access.
Antimicrobial and antithrombogenic coatings are being incorporated into newer devices to address infection and clot-related complications.
Safety-engineered devices are gaining adoption as healthcare providers seek to reduce needlestick injuries and improve procedural safety.
Integrated insertion systems are also emerging. These systems can combine multiple components into a streamlined workflow, potentially simplifying catheter placement and reducing procedural complexity.
Market Segmentation
By Type
Central vascular access devices currently represent a leading portion of the market because of their importance in long-term and high-acuity treatments such as chemotherapy, parenteral nutrition, and hemodialysis.
However, peripheral vascular access devices are expected to register the highest CAGR of 7.5% during the forecast period. Growth is supported by increasing hospital admissions, outpatient procedures, and demand for safer short-term vascular access.
By Route of Insertion
The subcutaneous route is expected to demonstrate the highest growth, with a projected CAGR of 7.7%. Increasing use of biologics, immunotherapies, and self-administered therapies is supporting demand for convenient and minimally invasive delivery approaches.
By Application
Drug administration accounted for the largest application share, representing 46.7% of the market in 2025. The segment benefits from the widespread use of vascular access for antibiotics, chemotherapy, biologics, critical-care medications, and infusion therapies.
By End User
Hospitals remain the dominant end-user segment, accounting for 51.8% of the market in 2025. Hospitals conduct large volumes of surgeries, emergency procedures, chemotherapy treatments, dialysis procedures, and critical-care interventions that require vascular access.
At the same time, clinics and ambulatory care centers are becoming increasingly important as healthcare systems shift toward outpatient treatment models.
Regional Market Outlook
North America currently represents a leading regional market due to its advanced healthcare infrastructure, high prevalence of chronic diseases, established vascular access programs, and adoption of premium medical technologies.
However, Asia Pacific is expected to register the highest growth during the forecast period. The region is benefiting from expanding healthcare infrastructure, increasing healthcare expenditure, rising surgical and hospitalization rates, growing oncology and dialysis populations, and government initiatives aimed at improving healthcare access.
Countries across the region are also increasing investments in advanced hospitals and diagnostic and treatment infrastructure, creating opportunities for vascular access device manufacturers.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=122149686
Challenges Facing the Vascular Access Device Industry
Despite strong growth prospects, manufacturers and healthcare providers face several challenges.
Product Failures and Recalls
Regulatory scrutiny remains high because vascular access devices come into direct contact with blood and can cause serious complications if they malfunction. Product failures and recalls can affect patient safety, manufacturer reputation, and market adoption.
Clinical Complications
Infection, thrombosis, vessel damage, bleeding, catheter malfunction, and other complications remain important concerns. These risks are increasing demand for improved device designs but can also limit adoption where appropriate training and infrastructure are unavailable.
Shortage of Skilled Professionals
The availability of clinicians trained in vascular access placement and management remains a challenge in several markets. As vascular access technologies become more sophisticated, healthcare organizations need adequately trained nurses, physicians, and specialists to achieve safe and effective utilization.
Competitive Landscape
The vascular access device market is characterized by the presence of established global medical device companies as well as emerging technology-focused manufacturers.
Major players identified by MarketsandMarkets include Becton, Dickinson and Company, Terumo Corporation, Teleflex, ICU Medical, B. Braun, Merit Medical Systems, Nipro Corporation, Vygon, AngioDynamics, Mozarc Medical, Spectrum Vascular, AMECATH, Medical Components (Medcomp), Healthline Medical Products, and Access Vascular.
Companies are focusing on portfolio expansion, product launches, strategic acquisitions, antimicrobial technologies, safety mechanisms, and advanced catheter materials to strengthen their market positions.
Recent Industry Developments
Recent developments demonstrate the industry’s movement toward safer and more integrated vascular access technologies. In April 2026, Becton, Dickinson and Company launched the BD CentroVena One Insertion System, an all-in-one central venous catheter insertion platform designed to consolidate multiple insertion components into a single system.
B. Braun has also expanded its central venous catheter portfolio with technologies incorporating antimicrobial and antithrombogenic coatings, while Teleflex expanded its vascular portfolio through the acquisition of BIOTRONIK’s Vascular Intervention business.
These developments highlight the industry’s focus on improving procedural efficiency, infection prevention, and patient safety.
Opportunities for Market Participants
The vascular access device market presents several attractive opportunities for manufacturers, technology developers, healthcare providers, and investors:
- Development of antimicrobial and antithrombogenic vascular access technologies
- Growth of ultrasound-guided insertion systems
- Expansion of peripheral IV and midline catheter portfolios
- Increasing demand for home infusion and outpatient care solutions
- Development of safer and easier-to-use insertion systems
- Expansion of vascular access technologies in emerging markets
- Increasing demand from oncology and dialysis applications
- Innovation in catheter materials and surface technologies
- Growth of integrated and closed vascular access systems
Future Outlook
The vascular access device market is expected to remain an important segment of the global medical devices industry through 2031. Growing chronic disease prevalence, expanding cancer and dialysis treatment volumes, increased healthcare utilization, and the transition toward outpatient and home-based care will continue to support demand.
At the same time, the competitive landscape will increasingly favor companies capable of combining patient safety, infection prevention, procedural efficiency, durability, and ease of use.
With the market projected to reach USD 8.70 billion by 2031 at a CAGR of 6.7%, vascular access device manufacturers have significant opportunities to differentiate through next-generation catheter technologies, image-guided access, antimicrobial protection, and integrated insertion solutions.
